SCHEMBL4954092

SCHEMBL4954092

O=C(COc1ccc(Cl)c(F)c1)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ATF4 P18848 6/20 0.56
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
HTR1A P08908 4/20 0.44
HTR2A P28223 4/20 0.44
HTR7 P34969 4/20 0.44
HTR6 P50406 4/20 0.44
PDK2 Q15119 5/20 0.43
GHSR Q92847 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953792 0.89 RAB9A (0.61) NPC1RAB9AHTR1AHTR2AHTR7
SCHEMBL4949410 0.86 FKBP1A (0.52) RAB9AHTR1AHTR2AHTR7HTR6
SCHEMBL4951152 0.86 HTR1A (0.55) RAB9AHTR1AHTR2AHTR7HTR6
SCHEMBL4948828 0.85 ENPP2 (0.49) HTR1AHTR2AHTR7HTR6PDK2
SCHEMBL4952558 0.85 FKBP1A (0.56) HTR1AHTR2AHTR7HTR6
SCHEMBL4955662 0.85 NPC1 (0.60) NPC1RAB9AHPGD
SCHEMBL4954896 0.85 ENPP2 (0.50) HTR1AHTR2AHTR7HTR6HPGD
SCHEMBL13996781 0.84 RAB9A (0.58) NPC1RAB9APDK2GHSRHPGD
SCHEMBL4953282 0.83 HTR1A (0.46) HTR1AHTR2AHTR7HTR6GHSR
SCHEMBL4951646 0.83 MEN1 (0.58) HTR1AHTR2AHTR7HTR6GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 ATF4 1751/4885NPC1 313/4885RAB9A 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.